SCHEMBL27186192

SCHEMBL27186192

COC(=O)c1cc(CN(C)C)c(OC)c2c[nH]nc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.34
▸ KDM4E B2RXH2 5/20 0.34
▸ HPGD P15428 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ MAPT P10636 3/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ NR4A2 P43354 4/20 0.33
▸ POLB P06746 3/20 0.33
▸ CCNE2 O96020 1/20 0.33
▸ CCNE1 P24864 1/20 0.33
▸ CDK2 P24941 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ G6PD P11413 1/20 0.32
▸ PABPC1 P11940 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27186394 0.89 ALDH1A1 (0.36) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL30853309 0.88 ALDH1A1 (0.34) ALDH1A1KDM4EMEN1KMT2AMAPT
SCHEMBL27186349 0.78 NR4A2 (0.40) ALDH1A1KDM4EHPGDNPSR1MAPT
SCHEMBL27186983 0.78 KDM4E (0.38) ALDH1A1KDM4EHPGDNPSR1MAPT
SCHEMBL29844202 0.72 SOS1 (0.38) MEN1KMT2ALMNAHTTPOLB
SCHEMBL14372992 0.72 ALDH1A1 (0.40) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL27187216 0.71 EGFR (0.39) ALDH1A1KDM4EHPGDNPSR1NR4A2
SCHEMBL19612171 0.70 ALDH1A1 (0.41) ALDH1A1KDM4EHPGDMEN1KMT2A
SCHEMBL27186154 0.70 UCHL1 (0.32) ALDH1A1KDM4EHPGDNPSR1NR4A2
SCHEMBL27186177 0.69 PDK2 (0.36) ALDH1A1KDM4EHPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2024-04-04 — — US disclosed
WO-2022187266-A1 NOVEL SUBSTITUTED BICYCLI AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2022-09-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109887-A1 NOVEL SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS SOS1, SOS2, KSR1 ALDH1A1 3733/4885KDM4E 1518/4885HPGD 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback